Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

@article{Sano2004GastricCS,
  title={Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.},
  author={Takeshi Sano and Mitsuru Sasako and Seiichiro Yamamoto and Atsushi Nashimoto and Akira Kurita and Masahiro Hiratsuka and Toshimasa Tsujinaka and Taira Kinoshit{\'a} and Kuniyoshi Arai and Yoshitaka Yamamura and Kunio Okajima},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2004},
  volume={22 14},
  pages={2767-73}
}
PURPOSE Radical gastrectomy with regional lymphadenectomy is the only curative treatment option for gastric cancer. The extent of lymphadenectomy, however, is controversial. The two European randomized trials only reported an increase in operative morbidity and mortality, but failed to show survival benefit, in the D2 lymphadenectomy group. We conducted a randomized controlled trial to compare the Japanese standard D2 and D2 + para-aortic nodal dissection. PATIENTS AND METHODS Only… CONTINUE READING
Highly Influential
This paper has highly influenced 24 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 269 extracted citations

Similar Papers

Loading similar papers…